We are live on ! Find out more
SGMO

SANGAMO THERAPEUTICS INC
SGMO

Delisted

SGMO was delisted on the 4th of May, 2026.

Back to rankings

156 hedge funds and large institutions have $747M invested in SANGAMO THERAPEUTICS INC in 2014 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 56 increasing their positions, 34 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,333% more call options, than puts

Call options by funds: $199M | Put options by funds: $8.16M

65% more repeat investments, than reductions

Existing positions increased: 56 | Existing positions reduced: 34

46% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 24

8% more funds holding

Funds holding: 145 → 156 (+11)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

14% less capital invested

Capital invested by funds: $869M → $747M (-$122M)

Holders
156
Holders Change
+11
Holders Change %
+7.59%
% of All Funds
4.48%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
35
Increased
56
Reduced
34
Closed
24
Calls
$199M
Puts
$8.16M
Net Calls
+$190M
Net Calls Change
-$34.2M

Top Buyers

Rank Fund Capital Flow
1
FCM
Frontier Capital Management
Massachusetts
+$13M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$5.83M
3
SM
Sabby Management
Florida
+$3.83M
4
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$3.2M
5
CNB
City National Bank
California
+$3.17M

Top Sellers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
-$35M
2
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$5M
3
BFA
BlackRock Fund Advisors
California
-$4.67M
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$3.6M
5
Bank of America
Bank of America
North Carolina
-$2.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
Goldman Sachs
26
Goldman Sachs
New York
$7.18M +$830K +57,696 +14%
Morgan Stanley
27
Morgan Stanley
New York
$6.89M -$485K -33,706 -7%
AWMDMG
28
Austin W. Marxe & David M. Greenhouse
New York
$6.87M – – –
SM
29
Sabby Management
Florida
$6.77M +$3.83M +266,021 +150%
CNB
30
City National Bank
California
$6.53M +$3.17M +220,009 +106%
Wellington Management Group
31
Wellington Management Group
Massachusetts
$6.19M +$5.83M +405,120 New
Geode Capital Management
32
Geode Capital Management
Massachusetts
$5.87M +$261K +18,140 +5%
TCIM
33
TIAA CREF Investment Management
New York
$5.85M +$378K +26,300 +7%
Bank of New York Mellon
34
Bank of New York Mellon
New York
$5.63M +$275K +19,106 +5%
Fidelity International
35
Fidelity International
Bermuda
$5.38M +$672K +46,730 +15%
CCM
36
Cupps Capital Management
Illinois
$5.25M +$1.24M +86,531 +34%
AGA
37
Altrinsic Global Advisors
Connecticut
$5.19M +$1.44M +100,000 +42%
Allianz Asset Management
38
Allianz Asset Management
Germany
$4.74M -$249K -17,301 -5%
UBS AM
39
UBS AM
Illinois
$3.67M – – –
Susquehanna International Group
40
Susquehanna International Group
Pennsylvania
$3.04M +$1.17M +81,193 +69%
Charles Schwab
41
Charles Schwab
California
$2.89M +$249K +17,296 +10%
D.E. Shaw & Co
42
D.E. Shaw & Co
New York
$2.88M +$993K +68,994 +58%
BIM
43
BlackRock Investment Management
Delaware
$2.84M +$28.7K +1,998 +1%
Millennium Management
44
Millennium Management
New York
$2.78M +$2.62M +182,315 New
QBFM
45
QS Batterymarch Financial Management
New York
$2.71M +$2.36M +163,859 +1,232%
GC
46
Guggenheim Capital
Illinois
$2.67M -$106K -7,336 -4%
Bank of America
47
Bank of America
North Carolina
$2.62M -$2.8M -194,390 -53%
Citadel Advisors
48
Citadel Advisors
Florida
$2.58M +$1.47M +101,898 +153%
California Public Employees Retirement System
49
California Public Employees Retirement System
California
$2.47M +$116K +8,065 +5%
TC
50
TFS Capital
Pennsylvania
$2.46M +$2.32M +160,922 New
1
2
3 4 5

SGMO Hedge Fund Activity: Q2 2014 in Review

156 of the 3,481 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q2 2014, worth a combined $747M — down 14% from $869M a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new SGMO positions and 24 closed out — a net gain of 11 holders — while 56 added to existing stakes and 34 trimmed.

The largest buyer was Frontier Capital Management, adding an estimated $13M. The largest seller was RA Capital Management, cutting an estimated $35M.

  • 156 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q2 2014, up from 145 in Q1 2014.
  • Funds reported $747M of SANGAMO THERAPEUTICS INC stock for Q2 2014, down 14% quarter-over-quarter.
  • 35 funds opened new SANGAMO THERAPEUTICS INC positions in Q2 2014 and 24 closed out, a net change of +11 holders.
  • The largest SANGAMO THERAPEUTICS INC buyer in Q2 2014 was Frontier Capital Management, an estimated $13M added.
  • The largest SANGAMO THERAPEUTICS INC seller in Q2 2014 was RA Capital Management, an estimated $35M sold.

Based on aggregated 13F filings for Q2 2014.